Nifedipine, a calcium channel blocker, inhibits advanced glycation end product (AGE)-elicited mesangial cell damage by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gamma activation

Diabetic Vascular Complications: Pathophysiology, Biochemical Basis and Potential Therapeutic Strategy

2005 • 436 citations

Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice

2005 • 421 citations

Pigment Epithelium-derived Factor Inhibits Advanced Glycation End Product-induced Retinal Vascular Hyperpermeability by Blocking Reactive Oxygen Species-mediated Vascular Endothelial Growth Factor Expression

2006 • 208 citations

Molecular Mechanisms of Diabetic Nephropathy and Its Therapeutic Intervention

2007 • 145 citations

Thiazolidinediones Reduce Endothelial Expression of Receptors for Advanced Glycation End Products

2004 • 135 citations

Detection of Noncarboxymethyllysine and Carboxymethyllysine Advanced Glycation End Products (AGE) in Serum of Diabetic Patients

1999 • 120 citations

Telmisartan inhibits AGE-induced C-reactive protein production through downregulation of the receptor for AGE via peroxisome proliferator-activated receptor-gamma activation

2006 • 107 citations

Nifedipine and enalapril equally reduce the progression of nephropathy in hypertensive type 2 diabetics

2001 • 91 citations

Kinetics, Role and Therapeutic Implications of Endogenous Soluble form of Receptor for Advanced Glycation end Products (sRAGE) in Diabetes

2007 • 71 citations

Role of Oxidative Stress in the Development of Vascular Injury and its Therapeutic Intervention by Nifedipine

2008 • 48 citations

Intervention with cilostazol attenuates renal inflammation in streptozotocin-induced diabetic rats

2008 • 42 citations

Optimal control of blood pressure in patients with diabetes reduces the incidence of macro and microvascular events

2007 • 33 citations